IP Library Granted Patent US 12,562,281
Granted Patent B2
US 12,562,281 · App. 17/447,252 · Granted Feb 24, 2026

Predictive risk assessment in patient and health modeling

Inventors: Nabil A. Abu El Ata (New York, NY); Annie Drucbert (New York, NY); Tomy Abu El Ata (New York, NY)
Assignee: X-Act Science, Inc.
G16H50/30G16H10/60G16H15/00G16H50/20G16H50/50
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,562,281
App. No.
17/447,252
Granted
Feb 24, 2026
Kind
B2
Abstract

A patient's health is modeled through multiple scenarios. A base model incorporates rules that govern a response by a human being to one or more diseases, as well as a relation between health metrics and the diseases. Health attributes of the patient are obtained. From the base model and the health attributes, a patient model is generated. The patient model is modeled under different parameters to generate health metrics. From an analysis of the parameters and the resulting health metrics, occurrence probabilities for each of the sets of parameters are determined. Risks are identified, which indicate a likelihood of the patient transitioning from the initial state to an adverse outcome such as a diseased state. A report provides a diagnosis of the patient and one or more remedies/interventions that are predicted, based on the plural sets of parameters and resulting health metrics, to avoid or prevent an adverse outcome.

Claims (55)

1 . A computer-implemented method of providing a digital computer simulation of health of a human patient, comprising:

obtaining in computer memory, a base model of a human being, the base model being a mathematical model incorporating rules that govern 1) a response by the human being to a disease, and 2) a relation between health metrics and the disease, the health metrics including a resistance metric indicating a measure of resistance to the disease, said obtaining being automatically performed by a processor;

obtaining in computer memory, by the processor, health attributes of the human patient, the health attributes including at least one of a genetic trait, a blood lipid profile, and a representation of a medical imaging report;

responsively generating in computer memory, by the processor, a patient model from the base model and the health attributes of the human patient, the patient model incorporating a patient-specific representation of the rules of the base model and a representation of the health attributes, the patient-specific representation of the rules of the base model including rules that govern response by the patient to a certain disease;

generating in computer memory, by the processor, plural sets of parameters, each of the plural sets of parameters indicating respective variables having a causal relation to the health metrics;

automatically generating a computer precision medicine evaluation of the patient by executing the patient model using a deterministic model, said executing being performed by the processor and producing: (a) respective simulations of the health metrics of the patient model under the plural sets of parameters over a given simulated time period,

(b) plural resistance metric results based on the deterministic model, each of the plural resistance metric results indicating a change in the resistance metric under a respective set of parameters over the given simulated time period, and

(c) an occurrence probability of the patient model transitioning from an initial state to each of a plurality of successive states during the given simulated time period, each of the successive states corresponding to a respective one of the plural sets of parameters, wherein the produced respective simulations, plural resistance metric results, and occurrence probability support the computer precision medicine evaluation of the patient with respect to at least the certain disease;

automatically determining a risk, by the processor, based on the produced simulations, the plural resistance metric results, and the occurrence probability of the generated precision medicine evaluation, the risk being of the patient model transitioning from the initial state to a diseased state, the diseased state representing the patient being afflicted by the certain disease;

automatically determining, by the processor, a diagnosis and a remedy, the remedy being determined by 1) identifying a subset of the health metrics that are negatively correlated with the diseased state, and 2) identifying the remedy as one of the respective variables associated with the identified subset of health metrics, the remedy identifying a modification to the patient model that reduces the determined risk;

generating as clinically-actionable output, by the processor, a map indicating 1) the processor determined diagnosis of the patient based on the determined risk, and 2) the determined remedy, said generating output being in a manner controlling computer diagnosis of patent-specific outcomes; and

responsive to the clinically-actionable output, treating the patient in accordance with the remedy by administering to the patient one or more of: a medication, physical therapy, and other therapy.

2 . The method of claim 1 , wherein the base model incorporates rules that govern a response by the human being to at least one of immune reactivations, irregular immune response, autoimmunity, preexisting conditions and environmental parameters.

3 . The method of claim 1 , wherein the health metrics of the base model in computer memory include indications of human health dependability (HHD), the HHD being a measure of an integrity of an immune system to counteract the disease.

4 . The method of claim 1 , wherein the certain disease is a first disease; and wherein the plural sets of parameters in computer memory include at least one set of parameters indicating comorbidity of the first disease and a second disease.

5 . The method of claim 1 , wherein the certain disease is one of a cancer, a virus, and a bacterial infection.

6 . The method of claim 1 , further comprising:

identifying, by the processor, a correspondence between a subset of the health attributes, the produced plural resistance metric results, and the determined risk; and

determining, by the processor, the diagnosis based on the identified correspondence, the diagnosis indicating the subset of health attributes that exceed a threshold correspondence with the determined risk.

7 . The method of claim 1 , further comprising:

updating the patient model in computer memory to incorporate the modification; and

determining an expected improvement to a measure of an integrity of the patient's immune system to counteract the certain disease, the updating and determining being automatically performed by the processor.

8 . The method of claim 7 , further comprising reporting the remedy to a user.

9 . The method of claim 7 , wherein determining the remedy includes the processor:

generating an additional set of parameters in computer memory, the additional set of parameters indicating a health intervention, the health intervention including at least one of a medication, a therapy, and a diet;

responsively modeling the health metrics of the patient model in computer memory under the additional set of parameters to generate a resistance metric result; and

automatically identifying the remedy based on the health metrics associated with the health intervention.

10 . The method of claim 1 , wherein:

the map relates the diseased state to 1) corresponding instances of the plural sets of parameters and 2) the occurrence probability of the patient model transitioning from the initial state to the plurality of successive states; and

further comprising the processor determining, based on the map, at least one risk for at least one of the successive states of the patient model in computer memory, the at least one risk defining a probability of an outcome of the patient model including the diseased state.

11 . The method of claim 1 , further comprising the processor generating in computer memory a lookup table cross-referencing states of the patient model to corresponding ones of the risk.

12 . The method of claim 11 , wherein determining the risk includes the processor accessing the lookup table in computer memory using information on a given state of the patient or patient model.

13 . The method of claim 11 , further comprising the processor:

responsively analyzing a state of the patient; and

wherein determining the risk includes accessing the lookup table in computer memory using information on the state of the patient.

14 . The method of claim 11 , wherein the lookup table cross-references the states of the patient model to the corresponding ones of the risk and at least one remedy.

15 . The method of claim 1 , wherein the generating a patient model in computer memory includes the processor:

generating a dependency graph having a plurality of nodes representing the health attributes; and configuring dependencies between the plurality of nodes based on the rules.

16 . A non-transitory computer-readable medium comprising instructions that, when executed by a computer, provide a digital computer simulation of health of a human patient including causing the computer to:

obtain in computer memory, by a processor, a base model of a human being, the base model being a mathematical model incorporating rules that govern 1) a response by the human being to a disease, and 2) a relation between health metrics and the disease, the health metrics including a resistance metric indicating a measure of resistance to the disease;

obtain in computer memory, by the processor, health attributes of a human patient, the health attributes including at least one of a genetic trait, a blood lipid profile, and a representation of a medical imaging report;

responsively generate in computer memory, by the processor, a patient model from the base model and the health attributes of the human patient, the patient model incorporating a patient-specific representation of the rules of the base model and a representation of the health attributes, the patient-specific representation of the rules of the base model including rules that govern response by the patient to a certain disease;

generate in computer memory, by the processor, plural sets of parameters, each of the plural sets of parameters indicating respective variables having a causal relation to the health metrics;

automatically generate a computer precision medicine evaluation of the patient by executing the patient model using a deterministic model, said executing being performed by the processor, and producing: (a) respective computer simulations of the health metrics of the patient model under the plural sets of parameters over a given simulated time period,

(b) plural resistance metric results based on the deterministic model, each of the plural resistance metric results indicating a change in the resistance metric under a respective set of parameters over the given simulated time period, and

(c) an occurrence probability of the patient model transitioning from an initial state to each of a plurality of successive states during the given simulated time period, each of the successive states corresponding to a respective one of the plural sets of parameters, wherein the produced respective simulations, plural resistance metric results, and occurrence probability support the computer precision medicine evaluation of the patent with respect to at least the certain disease;

automatically determine a risk, by the processor, based on the produced simulations, the plural resistance metric results, and the occurrence probability of the generated precision medicine evaluation, the risk being of the patient model transitioning from the initial state to a diseased state, the diseased state representing the patient being afflicted by the certain disease;

automatically determine, by the processor, a diagnosis and a remedy, the remedy being determined by 1) identifying a subset of the health metrics that are negatively correlated with the diseased state, and 2) identifying the remedy as one of the respective variables associated with the identified subset of the health metrics, the remedy identifying a modification to the patient model that reduces the determined risk;

generate as clinically-actionable output, by the processor, a map indicating 1) the processor determined diagnosis of the patient based on the determined risk, and 2) the determined remedy, said generating output being in a manner controlling computer diagnosis of patient-specific outcomes; and

responsive to the clinically-actionable output, provide treatment to the patient in accordance with the remedy by administering one or more of: a medication, physical therapy, and other therapy.

17 . The computer-readable medium of claim 16 , further comprising instructions causing the computer to:

identify a correspondence between a subset of the health attributes, the produced plural resistance metric results, and the determined risk; and

determine the diagnosis based on the identified correspondence, the diagnosis indicating the subset of health attributes that exceed a threshold correspondence with the determined risk.

18 . The computer-readable medium of claim 16 , further comprising instructions causing the computer to:

automatically update in computer memory the patient model to incorporate the modification.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2022
From: ABU EL ATA, NABIL A.; DRUCBERT, ANNIE; ABU EL ATA, TOMY
To: X-ACT SCIENCE, INC.
Reel/Frame 059514/0188 →
Continuity (2)
Provisional Application 63076243 · Sep 9, 2020
Related Publication 20220076841A1 · Mar 10, 2022
References Cited (203)
US 5146591A · Bachman et al. · 1992 [cited by applicant]
US 5193183A · Bachman · 1993 [cited by applicant]
US 5195178A · Krieger et al. · 1993 [cited by applicant]
US 5208765A · Turnbull · 1993 [cited by applicant]
US 5233513A · Doyle · 1993 [cited by applicant]
US 5241645A · Cimral et al. · 1993 [cited by applicant]
US 5276877A · Friedrich et al. · 1994 [cited by applicant]
US 5297279A · Bannon et al. · 1994 [cited by applicant]
US 5446874A · Waclawsky et al. · 1995 [cited by applicant]
US 5486995A · Krist et al. · 1996 [cited by applicant]
US 5522014A · Clark et al. · 1996 [cited by applicant]
US 5539652A · Tegethoff · 1996 [cited by applicant]
US 5680590A · Parti · 1997 [cited by applicant]
US 5724556A · Souder et al. · 1998 [cited by applicant]
US 5724569A · Andres · 1998 [cited by applicant]
US 5726914A · Janovski et al. · 1998 [cited by applicant]
US 5729746A · Leonard · 1998 [cited by applicant]
US 5771370A · Klein · 1998 [cited by applicant]
US 5790789A · Suarez · 1998 [cited by applicant]
US 5801958A · Dangelo et al. · 1998 [cited by applicant]
US 5809282A · Cooper et al. · 1998 [cited by applicant]
US 5822749A · Agarwal · 1998 [cited by applicant]
US 5881268A · McDonald et al. · 1999 [cited by applicant]
US 5893074A · Hughes et al. · 1999 [cited by applicant]
US 5937165A · Schwaller et al. · 1999 [cited by applicant]
US 5953707A · Huang et al. · 1999 [cited by applicant]
US 5958009A · Friedrich et al. · 1999 [cited by applicant]
US 5984511A · Vasey-Glandon et al. · 1999 [cited by applicant]
US 5999734A · Willis et al. · 1999 [cited by applicant]
US 6003079A · Friedrich et al. · 1999 [cited by applicant]
US 6009256A · Tseng et al. · 1999 [cited by applicant]
US 6023706A · Schmuck et al. · 2000 [cited by applicant]
US RE36602E · Sebastian et al. · 2000 [cited by applicant]
US 6038540A · Krist et al. · 2000 [cited by applicant]
US 6067412A · Blake et al. · 2000 [cited by applicant]
US 6115718A · Huberman et al. · 2000 [cited by applicant]
US 6119125A · Glouderman et al. · 2000 [cited by applicant]
US 6145121A · Levy et al. · 2000 [cited by applicant]
US 6272507B1 · Pirolli et al. · 2001 [cited by applicant]
US 6311144B1 · Abu El Ata · 2001 [cited by applicant]
US 6327551B1 · Peterson et al. · 2001 [cited by applicant]
US 6370681B1 · Dellarocas et al. · 2002 [cited by applicant]
US 6393386B1 · Zager et al. · 2002 [cited by applicant]
US 6532465B2 · Hartley et al. · 2003 [cited by applicant]
US 6560569B1 · Abu El Ata · 2003 [cited by applicant]
US 6662355B1 · Caswell et al. · 2003 [cited by applicant]
US 6904449B1 · Quinones · 2005 [cited by applicant]
US 6990437B1 · Abu El Ata · 2006 [cited by applicant]
US 7031901B2 · Abu El Ata · 2006 [cited by applicant]
US 7035786B1 · Abu El Ata et al. · 2006 [cited by applicant]
US 7343406B1 · Buonanno et al. · 2008 [cited by applicant]
US 7389211B2 · Abu El Ata et al. · 2008 [cited by applicant]
US 7441249B2 · Adachi et al. · 2008 [cited by applicant]
US 7783468B2 · Abu el Ata et al. · 2010 [cited by applicant]
US 7881920B2 · Abu El Ata et al. · 2011 [cited by applicant]
US 8103456B2 · Doniger et al. · 2012 [cited by applicant]
US 8280657B2 · Van Gorp et al. · 2012 [cited by applicant]
US 8364519B1 · Basu et al. · 2013 [cited by applicant]
US 8577775B1 · Gerber · 2013 [cited by applicant]
US 10726362B2 · Abu El Ata · 2020 [cited by applicant]
US 11030551B2 · Abu El Ata · 2021 [cited by applicant]
US 11334831B2 · Abu El Ata et al. · 2022 [cited by applicant]
US 11392875B2 · Carstens · 2022 [cited by applicant]
US 11631480B1 · Linetsky et al. · 2023 [cited by applicant]
US 11862304B1 · Klein · 2024 [cited by applicant]
US 20010027527A1 · Khidekel et al. · 2001 [cited by applicant]
US 20010041996A1 · Eder · 2001 [cited by applicant]
US 20020069235A1 · Chen · 2002 [cited by applicant]
US 20020077717A1 · Harburda et al. · 2002 [cited by applicant]
US 20040128618A1 · Datta · 2004 [cited by applicant]
US 20040138933A1 · LaComb et al. · 2004 [cited by applicant]
US 20040167765A1 · Abu El Ata · 2004 [cited by applicant]
US 20040249482A1 · Abu El Ata et al. · 2004 [cited by applicant]
US 20050043977A1 · Ahern et al. · 2005 [cited by applicant]
US 20050144150A1 · Ramamurthy et al. · 2005 [cited by applicant]
US 20060241931A1 · Abu el Ata et al. · 2006 [cited by applicant]
US 20070219816A1 · Van Luchene et al. · 2007 [cited by applicant]
US 20070294121A1 · Galt et al. · 2007 [cited by applicant]
US 20070294128A1 · Wedemeyer · 2007 [cited by applicant]
US 20070299706A1 · Galt et al. · 2007 [cited by applicant]
US 20070299720A1 · Tafoya · 2007 [cited by applicant]
US 20080010082A1 · Jiang et al. · 2008 [cited by applicant]
US 20080162232A1 · Gamarnik et al. · 2008 [cited by applicant]
US 20080243543A1 · Jung et al. · 2008 [cited by applicant]
US 20080312986A1 · Braun et al. · 2008 [cited by applicant]
US 20090112668A1 · Abu El Ata · 2009 [cited by applicant]
US 20090182593A1 · Whitmore · 2009 [cited by applicant]
US 20090204234A1 · Sustaeta et al. · 2009 [cited by applicant]
US 20090254411A1 · Bhattacharya et al. · 2009 [cited by applicant]
US 20100004963A1 · Ficery et al. · 2010 [cited by applicant]
US 20100004977A1 · Marci et al. · 2010 [cited by applicant]
US 20100191472A1 · Doniger et al. · 2010 [cited by applicant]
US 20110078411A1 · Maclinovsky et al. · 2011 [cited by applicant]
US 20110295618A1 · Naipaul et al. · 2011 [cited by applicant]
US 20110295621A1 · Faroq et al. · 2011 [cited by applicant]
US 20120016714A1 · Apte et al. · 2012 [cited by applicant]
US 20120022939A1 · Tiwari et al. · 2012 [cited by applicant]
US 20120035962A1 · Liff · 2012 [cited by applicant]
US 20120046999A1 · Jayaraman et al. · 2012 [cited by applicant]
US 20120197686A1 · Abu El Ata · 2012 [cited by applicant]
US 20120210292A1 · Zhang et al. · 2012 [cited by applicant]
US 20120316930A1 · Clemenson · 2012 [cited by applicant]
US 20130060603A1 · Wagner · 2013 [cited by applicant]
US 20130282415A1 · Salto et al. · 2013 [cited by applicant]
US 20150333992A1 · Vasseur et al. · 2015 [cited by applicant]
US 20150339263A1 · Abu El Ata et al. · 2015 [cited by applicant]
US 20170140306A1 · Prabhu · 2017 [cited by applicant]
US 20170277841A1 · Shankar · 2017 [cited by examiner]
US 20190005200A1 · Zimmerman · 2019 [cited by examiner]
US 20190188615A1 · Liu · 2019 [cited by applicant]
US 20200387845A1 · Aasoori et al. · 2020 [cited by applicant]
US 20210158897A1 · Chatzou · 2021 [cited by examiner]
US 20210294946A1 · Hendriks · 2021 [cited by examiner]
US 20220061745A1 · Baldera · 2022 [cited by examiner]
US 20220375621A1 · Cheng · 2022 [cited by examiner]
US 20230024150A1 · Malone · 2023 [cited by examiner]
US 20230079951A1 · Bulut · 2023 [cited by examiner]
US 20230215580A1 · Sakata · 2023 [cited by examiner]
US 20230360802A1 · Jin · 2023 [cited by examiner]
US 20230394124A1 · Cronie · 2023 [cited by examiner]
Kamel Boulos, M.,N., & Zhang, P. (2021). Digital twins: From personalised medicine to precision public health. Journal of Personalized Medicine, (Year: 2021). [cited by examiner]
L. Abirami and J. Karthikeyan, “Digital Twin-Based Healthcare System (DTHS) for Earlier Parkinson Disease Identification and Diagnosis Using Optimized Fuzzy Based k-Nearest Neighbor Classifier Model,” in IEEE Access, vo… [cited by examiner]
Keshav, S., “Real User's Manual”, Oct. 21, 1993, URL: http://minnie.cs.adfa.oz.au/REAL/user.asc.gz. [cited by applicant]
Lazowska, E., et al., “Quantitative System Performance: Computer System Analysis Using Queueing Network Models”, Prentice-Hall, Inc., 1984, Table of Contents Only consisting of 8 pages. [cited by applicant]
Leymann, F., et al, “Production workflow: concepts and techniques”, 2000, Table of Contents Only consisting of 14 pages. [cited by applicant]
Lorenz, “The Essence of Chaos,” 1993, University of Washington Press, Chapter 2: a Journey Into Chaos, p. 69, 3rd-4th Paragraph. [cited by applicant]
Menasce, D., et al., “Capacity Planning and Performance Modeling”, 1994, Prentice-Hall, ISBN 0- 13-035494-5. [cited by applicant]
Morrison, “The Art of Modeling Dynamic Systems: Forecasting for Chaos, Randomness, and Determinism,” 1991, Turtle Hollow Associates, Inc. [cited by applicant]
“Model Driven Architecture (MDA) Document No. ormsc/2001-07-01”, Architecture Board ORMSC1, pp. 1-31, Jul. 2001. [cited by applicant]
“Performance and Capacity Management, BEST/I-Visualizer for AS/400,” http://www.bgs.com/as400/as4 _ home.htm (Printed: May 21, 1998), 2 pgs. [cited by applicant]
“Pyramid: Quantitative management: get a grip on software!” 100 pages, 1991. [cited by applicant]
Rechtin, E., “System Architecting”, Creating and Building Complex Systems, Prentice Hall, 1991, Table of Contents only, consisting of 5 pages. [cited by applicant]
“Reengineering,” from Wikipedia, the free encyclopedia, http://en.wikipedia.org/wiki/Reeingineering, downloaded Jan. 8, 2006, 2 pp. [cited by applicant]
Riolli, L., and Savicki, V. “Information System Organizational Resilience,” Omega: The International Journal of Management Science (31 :3), 2003, pp. 227-233. (Year: 2003). [cited by applicant]
Rolia, J.A. and K.C. Sevcik, “The Method of Layers,” IEEE Transactions on Software Engineering 21(8):689-700, Aug. 1995). [cited by applicant]
Sarris, D., et al., “The White Papers: Capacity Planning for e-Commerce Systems With Benchmark Factory™”, http://www.guest.com/whitepapers/caP_plan_Ecomm.pdf, pp. 1-19. No date given. [cited by applicant]
“SES—Products and Services: Why Simulate?” http://www.ses.com/whysimulate.html (Updated: Apr. 2, 1998), 7 pgs. from Capacity Management Review, vol. 36, No. 2, Feb. 1998. [cited by applicant]
“SES in the Press,” http://www.ses.com/news/html (Updated: Apr. 8, 1998), 3 pgs. [cited by applicant]
“SES Inc. Announces Release of Strategizer,” http://www.ses.com/pr_archive/010297.html (Updated: Jul. 14, 1997, 2 pgs. [cited by applicant]
“SES Releases SES/Workbench 3.1,” http://www.ses.com/pr_archive/022896.html (Updated Jul. 14, 1997), 3 pgs. [cited by applicant]
“SES/workbench: Workbench Overview,” http://www.ses.com/workbench.html (Updated: Feb. 10, 1998), 3 pgs. [cited by applicant]
“SES/objectbench: Batch Execution,” http://www.ses.com/Objectbench/sim_details_batch.html (Updated: Apr. 6, 1998), 2 pgs. [cited by applicant]
“SES/objectbench: The Objectbench Animated Simulator,” http://www.ses.com/Objectbench/simulator.html (Updated: Apr. 15, 1998), 2 pgs. [cited by applicant]
“SES/objectbench,” http://www.ses.com/Objectbench/index.html (Updated Apr. 6, 1998), 2 pgs. [cited by applicant]
Setzer, “Decision Support for Service Transition Management,” 2008, In NOMS 2008-2008 IEEE Network Operations and Management Symposium, pp. 200-207 (Year. 2008). [cited by applicant]
Shaw, M., et al., “Software Architecture: Perspectives on an Emerging Discipline”, Prentice Hall 1996, Table of Contents only consisting of 7 pages. [cited by applicant]
“Simulation modeling within workflow technology,” Miller, et al., Proceedings of the 1995 Winter Simulation Conference, Dec. 3-6, 1995. [cited by applicant]
Soley, R., et al., “Model Driven Architecture” Object Management Group, pp. 1-12 (Nov. 27, 2000). [cited by applicant]
“The Portable Simulation Initiative and the Common Modeling Framework,” http://www.ses.com/psi-cmf.html (Updated: Apr. 3, 1998), 3 pgs. [cited by applicant]
“UML Based Performance Modeling,” Chapter 5, pp. 75-167; no date provided. [cited by applicant]
US. Trademark Electronic Search System, search result for Trademark U.S. Appl. No. 74/555,204, filed Nov. 27, 2001. [cited by applicant]
White, R.V., “An Introduction to Six Sigma with a Design Example,” Applied Power Electronics Conference and Exposition, 1992. Conference Proceedings 1992, Seventh Annual, Fehr. 23-27, 1992, pp. 28-35. [cited by applicant]
Wickboldt, “Improving IT Change Management Processes with Automated Risk Assessment,” 2009, In IEEE International Workshop on Distributed Systems: Operations and Management, pp. 71-84 (Year: 2009). [cited by applicant]
“About BEST/I,” http://www.bgs.com/bgs.htm (Printed Out: May 21, 1998) 1 pg. [cited by applicant]
“Analyzing and re-engineering business process using simulation,” Bhskar, et al., Proceeding of the 1994 Winter Simulation Conference, Dec. 11-14, 1994. [cited by applicant]
Abu El Ata, N., “How we Avoided Murphy's Law at the Italian Stock Exchange”, CMG 1997, consisting of 7 pages. [cited by applicant]
Abu El Ata, N., “How Metrics and Models Made Architecture Real,” presented at DCI Conference in Washington, D.C. in Feb. 2000 (slides 1-21). [cited by applicant]
Abu El Ata, N., “A Predictive Modeling Approach to Developing Complex Systems,” presented at CSC Leading Edge Forum Conference on Mar. 6, 2001 (slides 1-32). [cited by applicant]
Abu El Ata, N., “System Performance Modeling”, ITC Meeting Minutes, Dec. 2, 1999, URL: http://www.istis.unomaha.edu/itc/meetings/m991202.htm. [cited by applicant]
Abu El Ata, N., “CMG97 Session Descriptions by Subject Area”, CMG97 Orlando, The Computer Measurement Group's 1997 Int'l Conference, Dec. 7-12, 1997, URL: http://www.cmg.org/cmg97/cmg97sessions.html and http://www.cmg.o… [cited by applicant]
Accretive/BT/Reuters, “Reuters, BT and Accretive Technologies Collaboration for Success,” 2005, 1 p. [cited by applicant]
Agrawal, S., et al., “The aggregate server method for analyzing serialization delays in computer systems”, ACM Transactions on Computer Systems, vol. 1, Issue 2, pp. 116-143, May 1983, ISSN: 0734-2071. [cited by applicant]
Altmann, M., “A list of software for computer simulations”, Last updated, Nov. 11, 1996. URL: http://www.nmsr.labmed.umn.edu/˜michael/dbase/outgoing/FAQ.html. [cited by applicant]
J. Barkley Rosser, Jr., “Computational and Dynamic Complexity in Economics” (Mar. 2007). [cited by applicant]
Bass, L., et al., “Software Architecture in Practice”, SEI Series in Software Engineering, Addison-Wesley, 1998, Table of Contents only, consisting of 8 pages. [cited by applicant]
Beck, K., “Extreme Programming Explained”, Addison-Wesley 2000, Table of Contents Only consisting-of 7 pages. [cited by applicant]
“BEST/I-Visualizer for AS/400, Product Description,” http://www.bgs.com/as400/Slid_2.html (Printed Out: May 21, 1998), 2 pgs. [cited by applicant]
“BEST/I-Visualizer for AS/400, Bottleneck Detection and Analysis,” http://www.bgs.com/as400/Slid_3.html (Updated: Nov. 22, 1996), 2 pgs. [cited by applicant]
“BEST/I-Visualizer for AS/400, Threshold Exception Reporting,” http://www.bgs.com/as400/Slid_4.html (Updated: Jan. 23, 1997), 2 pgs. [cited by applicant]
“BEST/I-Visualizer for AS/400, Track and Trend Long-term Performance,” http://www.bgs.com/as400/Slid_6.html (Printed Out: May 21, 1998) 2 pgs. [cited by applicant]
“BEST/I-Visualizer for AS/400, CPU/System Graphs,” http://www.bgs.com/as400/Slid_8.html (Updated: Nov. 29, 1996, 2 pgs. [cited by applicant]
“BEST/I-Visualizer for AS/400, 1/0 Subsystem Graphs,” http://www.bgs.com/as400/Slid_9.html (Updated: Nov. 30, 1996), 2 pgs. [cited by applicant]
“BEST/I-Visualizer for AS/400, Storage Pool Graphs,” http://www.bgs.com/as400/Slid_11.html (Updated: Nov. 22, 1996), 2 pgs. [cited by applicant]
“BEST/I-Visualizer for AS/400, Communication Line Graphs,” http://www.bgs.com/as400/Slid_12.htm1 (Updated: Nov. 30, 1996), 2 pgs. [cited by applicant]
“BEST/I-Visualizer for AS/400, Job Graphs,” http://www.bgs.com/as400/Slid_13.html (Updated: Jan. 22, 1997) 2 pgs. [cited by applicant]
“BEST/I-Visualizer for AS/400, Workload Analysis,” http://www.bgs.com/as400/Slid_5.html (Updated: Jan. 23, 1997), 2 pgs. [cited by applicant]
“BMC Software BEST/I,” http://www.bgs.com (Updated: Apr. 10, 1998), 1 pg. [cited by applicant]
“BMC Software to Acquire BGS Systems,” http://www.bgs.com/bmcbgs.htm (Printed Out: May 21, 1998), 3 pgs. [cited by applicant]
Boehm, B., “Software Engineering Economics”, Prentice Hall, 1981, Table of Contents only, consisting of 14 pages. [cited by applicant]
Bontempo, et al., “Database Management Principles and Products”, Prentice Hall, Inc., 1995, Table of Contents only consisting of 10 pages. [cited by applicant]
Booch, G., et al., “The Unified Modeling Language User Guide”, Addison Wesley Longman, Inc. 1999, Table of Contents only, consisting of 9 pages. [cited by applicant]
Chappell, D., “SOA: Is everyone talking the same language?”, Issue 15.3, Nov. 2005, pp. 1-4 http://www.ibspublishing.com/index.cfm?section=features&action=view&id=987. [cited by applicant]
Choukri, T., “Curriculum Vitae”, 1999. URL: http://www.global-coms.com/consultants/cv_choukri.htm. (With translation). [cited by applicant]
Compaq Open VMS Documentation, “TCP/IP Networking on Open VMS Systems”, Nov. 1996, URL: http://www.openvms.compaq.com:8000/ssb71/6436p.htm. [cited by applicant]
EETimes: Intel, Others Eye Performance Modeling Standard, http://www.techweb.com/se/directlink.cgi? EET19971103S0105 (Nov. 3, 1997), 2 pgs. [cited by applicant]
Eureka Project E!636. URL: http://www3.eureka.be/Home/projectdb/PrjFormFrame.asp?pr_id=636; retrieved from the Internet on Nov. 27, 2001. [cited by applicant]
“Euroexpert: GATE™,” Euroexpert SA, Antony, France (Sep. 1, 1997), 2 pgs. [cited by applicant]
“EuroExpert GATE™ Model Product Description: a predictive approach to efficient information systems”, pp. 1-21, 1994. [cited by applicant]
“Euroexpert: Best Practices: Milan Stock Exchange,” Euroexpert SA, Antony, Fanece (Sep. 1, 1997), 2 pgs. [cited by applicant]
“Euroexpert: Best Practices: France Telecom,” Euroexpert SA, Antony, France (Sep. 1, 1997), 2 pgs. [cited by applicant]
“Euroexpert-Best Practices: French Social Security—UNEDIC”, http://www.accretivetechnologies.com/documents/UNEDIC,PDF,EUROEXPERT and GATE (TM), 1992 Best Practices. [cited by applicant]
Grady, R., et al., “Software Metrics: Establishing a Company-Wide Program”, Prentice-Hall, Inc., Table of Contents only, consisting of 5 pgs., 1987. [cited by applicant]
Gunther, N., “The Practical Performance Analyst”, Performance-by-Design Techniques for Distributed Systems, McGraw-Hill, Table of Contents only consisting of9 pages, 1998. [cited by applicant]
Humphrey, W., “Managing the Software Process”, SEI Series in Software Engineering, Addison-Wesley, 1990, Table of Contents only, consisting of 7 pages. [cited by applicant]
Hutchins, G., “ISO 9000, a Comprehensive Guide to Registration, Audit Guidelines, and Successful Certification” (Oliver Wight Publications, Inc.) 1993, Table of Contents Only consisting of 5 pages. [cited by applicant]
Jacobson, I., et al., “Software Reuse”, Architecture Process and Organization for Business Success, ACM Press, Table of Contents only, consisting of9 pages, Addison-Wesley, 1997. [cited by applicant]
Kahkipuro, P., “Performance Modeling Framework for CORBA Based Distributed Systems,” Department of Computer Science Series of Publications a Report A-2000-3, Finland, University of Helsinki (2000). [cited by applicant]
Kellert, “In the Wake of Chaos: Unpredictable Order in Dynamical Systems,” 1993, University of Chicago Press. [cited by applicant]
Keshav, S., “Real 5.0 Overview”, Aug. 13, 1997, URL: http://www.cs.comell.edu/skeshav/real/overview.html. [cited by applicant]
Keshav, S., “Real 5.0 User Manuals”, Aug. 13, 1997, URL: http://www.cs.comell.edu/skeshav/real/user.html. [cited by applicant]
Keshav, S., “Real 5.0 Programmer's Manual”, Aug. 13, 1997, URL: http://www.cs.cornell.edu/skeshav/real/prog.html. [cited by applicant]
Keshav, S., “Real 5.0 Changes”, Aug. 13, 1997, URL: http://www.cs.comell.edu/skeshav/real/changes.html. [cited by applicant]
Keshav, S., “Real Programmer's Manual”, Oct. 21, 1993, URL: http://minnie.cs.adfa.oz.au/REAL/prog.asc.gz. [cited by applicant]